ibrutinib,obinutuzumab,venetoclax,rituximab
abbvie,janssen,roche
['cll13', 'cll', 'venetoclax', 'gaia']
tausch #ash22 #cll
genetic insights from cll13 (fcr/br v rv v gv v giv)
umrd similar across muts with ven-rx
ighv status, ckt, notch1 prognostic in cit and ven-containing rx for pfs
ras/raf mut prognostic for ven-regimens but not cit for pfs
notch1 &amp; ras/raf worth further study 
Doc from Melbourne, Australia. Treats patients with blood cancers and researches new therapies. Loves family, immersive theatre and running.